Article contents
Oxypertine in Tardive Dyskinesia: An 8-week Controlled Study
Published online by Cambridge University Press: 29 January 2018
Summary
In a double-blind placebo controlled trial of oxypertine in the treatment of tardive dyskinesia, 33 patients with chronic schizophrenia received either oxypertine or placebo. At the end of eight weeks, the results showed that oxypertine was superior to placebo at a statistically significant level.
- Type
- Research Article
- Information
- Copyright
- Copyright © 1984 The Royal College of Psychiatrists
References
- 6
- Cited by
eLetters
No eLetters have been published for this article.